Siemens Healthineers AG (OTCMKTS:SMMNY) Given Average Rating of “Buy” by Brokerages

Siemens Healthineers AG (OTCMKTS:SMMNY) has been assigned an average rating of “Buy” from the seven research firms that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and three have given a strong buy recommendation to the company.

A number of equities analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft cut Siemens Healthineers from a “buy” rating to a “hold” rating in a report on Thursday, December 4th. Sanford C. Bernstein upgraded Siemens Healthineers to a “strong-buy” rating in a research report on Tuesday, January 13th. Zacks Research raised shares of Siemens Healthineers from a “strong sell” rating to a “hold” rating in a research note on Monday, January 12th. Royal Bank Of Canada assumed coverage on shares of Siemens Healthineers in a research report on Wednesday, December 17th. They set a “moderate buy” rating for the company. Finally, Citigroup reiterated a “buy” rating on shares of Siemens Healthineers in a research report on Friday, January 23rd.

Siemens Healthineers Trading Down 2.5%

Shares of Siemens Healthineers stock opened at $23.48 on Friday. The firm has a 50-day simple moving average of $25.50 and a two-hundred day simple moving average of $26.30. Siemens Healthineers has a fifty-two week low of $23.22 and a fifty-two week high of $29.00.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.